Evidence map›Paper›PMID 41179634›Full record

ArticleArchives of Razi Institute2025

The severity of COVID-19 infection correlation with IL-17 polymorphism.

Abdulateef Abdullah Zina, Fouad Ali Layla

Abstract read
In one paragraph

Article in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abdulateef Abdullah ZinaUniversity of Baghdad, College of Science, Department of Biology, Baghdad, Iraq.
Fouad Ali LaylaUniversity of Baghdad, College of Science, Department of Biology, Baghdad, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single nucleotide polymorphisms (SNPs) in many studied genes have been related to the severity of COVID-19. This study was carried out to investigate whether the polymorphisms of two SNPs (rs763780 and rs2275913) of the gene polymorphisms for Interleukin 17 (IL-17) are connected to the COVID-19 severity. The effect of these polymorphisms on the levels of IL-17 and the relationship between the level of IL-17 and the severity of COVID-19 were also investigated. The real-time polymerase chain reaction (RT-PCR) was performed to detect SARS-COV-2. Blood samples were obtained for the analyses of IL-17 levels by enzyme-linked immunosorbent assay, and Genomic DNA was extracted for genotyping. It should be noted that genotyping was performed using RT-PCR. The results indicated that the IL-17 level significantly increased in the case group, compared to the control group (healthy people), and there was a relationship between the severity of COVID-19 and IL-17 levels (

Indexed as

COVID-19Interleukin-17Polymorphism, Single NucleotideAdultAgedCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedSARS-CoV-2Severity of Illness IndexIL17A protein, humanInterleukin-17COVID-19HRM RT-PCRInterleukin-17Polymorphism, RT-PCRSARS-CoV-2, SNP

Identifiers

PMID41179634
PMCPMC12572676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.